Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fibrogen Inc CS (FGEN)

Fibrogen Inc CS (FGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,005,556
  • Shares Outstanding, K 86,916
  • Annual Sales, $ 212,960 K
  • Annual Income, $ -86,420 K
  • 60-Month Beta 1.84
  • Price/Sales 14.51
  • Price/Cash Flow N/A
  • Price/Book 5.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.39
  • Number of Estimates 5
  • High Estimate 0.03
  • Low Estimate -0.82
  • Prior Year 0.23
  • Growth Rate Est. (year over year) -269.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.33 +8.20%
on 11/12/19
48.44 -27.79%
on 11/08/19
-3.05 (-8.02%)
since 10/14/19
3-Month
32.33 +8.20%
on 11/12/19
48.44 -27.79%
on 11/08/19
-8.37 (-19.31%)
since 08/14/19
52-Week
32.33 +8.20%
on 11/12/19
61.23 -42.87%
on 02/28/19
-4.51 (-11.42%)
since 11/14/18

Most Recent Stories

More News
FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against FibroGen, Inc. (NASDAQ: FGEN) on behalf of FibroGen stockholders. Our investigation...

FGEN : 34.98 (+1.16%)
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors who have suffered significant losses to submit their loss now to learn if they qualify to recover their investment losses. The firm is investigating...

FGEN : 34.98 (+1.16%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of FibroGen, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) investors concerning the Company and its officers' possible violations...

FGEN : 34.98 (+1.16%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of FibroGen, Inc. Investors

Law Offices of Howard G. Smith announces an investigation on behalf of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) investors concerning the Company and its officers' possible violations...

FGEN : 34.98 (+1.16%)
SmarTrend Watching for Potential Rebound in Shares of Fibrogen Inc After 3.97% Loss

Fibrogen Inc (NASDAQ:FGEN) traded in a range yesterday that spanned from a low of $34.14 to a high of $35.69. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $34.35...

FGEN : 34.98 (+1.16%)
Fibrogen Inc is Among the Companies in the Biotechnology Industry with the Best Relative Performance (FGEN , NVTA , FOLD , SRPT , CYTK )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

FOLD : 9.35 (-2.09%)
FGEN : 34.98 (+1.16%)
NVTA : 17.39 (+0.06%)
FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates

FibroGen (FGEN) delivered earnings and revenue surprises of 3.39% and 8.13%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

FGEN : 34.98 (+1.16%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN

Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

FGEN : 34.98 (+1.16%)
FibroGen Reports Third Quarter 2019 Financial Results

-- Roxadustat Positive Pooled Phase 3 Efficacy and Cardiovascular Safety Data Presented Last Friday at American Society of Nephrology 2019 Kidney Week

FGEN : 34.98 (+1.16%)
FibroGen (FGEN) Soars: Stock Adds 9.6% in Session

FibroGen (FGEN) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

IRWD : 11.60 (+1.98%)
FGEN : 34.98 (+1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade FGEN with:

Business Summary

FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development...

See More

Key Turning Points

2nd Resistance Point 36.45
1st Resistance Point 35.71
Last Price 34.98
1st Support Level 34.04
2nd Support Level 33.11

See More

52-Week High 61.23
Fibonacci 61.8% 50.19
Fibonacci 50% 46.78
Fibonacci 38.2% 43.37
Last Price 34.98
52-Week Low 32.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar